|
Re: Working thread - what do you think the HER2+ standard of care should be really?
So here's a new issue that has come up in a couple of cancer discussion boards recently: Why must we all receive the maximum tolerated dose? Why is that the standard of care? An article recently suggested that it might be better giving long-term patients lower doses, once the cancer is under control, to ward off resistance. (I'll see if I can find the article.)
Makes sense to me.
__________________
June 2015 - Stage IV, HER2+++, HR-. Mets to liver, assorted lymph nodes.
June 2015 - Begin THP
October 2015 - End THP, begin H&P. PET-CT shows resolution of mets to liver & lymph nodes.
|
Hybrid Mode
